首页> 外文期刊>Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society >Hepatic Venous Outflow Obstruction in Pediatric Living Donor Liver Transplantation Using Left-Sided Lobe Grafts: Kyoto University Experience
【24h】

Hepatic Venous Outflow Obstruction in Pediatric Living Donor Liver Transplantation Using Left-Sided Lobe Grafts: Kyoto University Experience

机译:左叶移植术在小儿活体供体肝移植中肝静脉流出障碍:京都大学的经验

获取原文
获取原文并翻译 | 示例
           

摘要

The goals of this study were to evaluate the incidence of hepatic venous outflow obstruction (HVOO) in pediatric patients after living donor liver transplantation (LDLT) using left-sided lobe grafts and to assess the therapeutic modalities used for the treatment of this complication at a single center. Four hundred thirteen primary LDLT procedures were performed with left-sided lobe grafts between 1996 and 2006. All transplants identified with HVOO from a cohort of 380 grafts with survival greater than 90 days were evaluated with respect to the patient demographics, therapeutic intervention, recurrence, and outcome. Seventeen cases (4.5%) were identified with HVOO. Eight patients experienced recurrence after the initial balloon venoplasty. Two patients finally required stent placement after they experienced recurrence shortly after the initial balloon venoplasty. A univariate analysis revealed that a smaller recipient-to-donor body weight ratio and the use of reduced grafts were statistically significant risk factors. The cases with grafts with multiple hepatic veins had a higher incidence of HVOO. In conclusion, the necessity of repeated balloon venoplasty and stent placement was related to poor graft survival. Therefore, the prevention of HVOO should be a high priority in LDLT. When grafts with multiple hepatic veins and/or significant donor-recipient size mismatching are encountered, the use of a patch graft is recommended. Stent placement should be carefully considered because of the absence of data on the long-term patency of stents and stent-related complications. New stenting devices, such as drug-eluting and biodegradable stents, may be promising for the management of HVOO. Liver Transpl 16: 1207-1214, 2010.
机译:这项研究的目的是评估使用左叶移植物进行活体供体肝移植(LDLT)后小儿患者肝静脉流出道阻塞(HVOO)的发生率,并评估用于治疗该并发症的治疗方式。单中心。在1996年至2006年之间,对左侧肺叶移植物进行了413次主要LDLT手术。对380例移植物中存活时间超过90天的所有HVOO鉴定的移植进行了患者人口统计学,治疗干预,复发,和结果。 HVOO确诊了17例(4.5%)。最初的球囊静脉成形术后,八名患者复发。两名患者在最初的球囊静脉成形术后不久便复发,最终需要放置支架。单因素分析表明,较小的受者与受者体重比和减少移植物是统计学上显着的危险因素。移植有多条肝静脉的病例HVOO的发生率较高。总之,重复进行球囊静脉成形术和支架置入的必要性与移植物存活差有关。因此,在LDLT中,预防HVOO应该成为高度优先事项。当遇到具有多条肝静脉的移植物和/或明显的供体-受体大小不匹配时,建议使用补片移植物。由于缺乏有关支架的长期通畅性和支架相关并发症的数据,应仔细考虑支架的放置。诸如药物洗脱支架和可生物降解支架等新型支架设备对于HVOO的管理可能很有希望。 Liver Transpl 16:1207-1214,2010。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号